Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001...
-
Upload
alannah-garrison -
Category
Documents
-
view
216 -
download
0
Transcript of Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001...
![Page 1: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/1.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
1
Stroke Epidemiology-2001
Aurora K. Pajeau, M.D., MPHStroke Director
LSUHSC-Shreveport
![Page 2: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/2.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
2
Stroke-2001
• 3rd leading cause of death in the United States
• A major cause of disability among adults.
• Estimated 750,000 annual incident strokes.
• >4 million stroke survivors.
![Page 3: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/3.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
3
Well-Documented Modifiable
Stroke Risk Factors
HTN (Age 50-80) 20-55% 40-20 4.0-1.4 38%
Smoking 25% 12-18 1.8 50% /c 1yr
DM 20% 14-58 1.8-6 /c BP Asxto Carotid Stn 2-8% 2-7 2.0 50%
TC men 55y 25% 25 1.8/ 240-279 20-30% women 65y 40% 2.6/>280 /c statinsA Fib 0.5-8.8% 1.5-23 5 2.6-4.5 68% A/C
21%ASAAdapted from Goldstein et al: Stroke 2001;32:280-299
Factor Prevalence PAR% RR %Risk /c Tx
![Page 4: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/4.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
4
Hyperlipidemia
~36% (60x106) adults in U.S.
Mean TC levels increase in men till age 55-64 then decline.
25% of American men and 28% of women have TC levels >240mg/dl (6.21mm/l)
![Page 5: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/5.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
5
Normal Endothelium
![Page 6: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/6.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
6
Fibrous Plaque
![Page 7: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/7.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
7
![Page 8: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/8.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
8
Stimuli Initiating Atherosclerosis
Hypertension Mechanical forces, sheer stress response
Oxidized LDL Adhesion, permeability, deposition
Homocysteine[O] LDL, vascular toxin
Cigarettes Toxic, oxidizing glycation products
Hyperglycemia Arterial retention of Trigl
Infection Vessel wall injury
![Page 9: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/9.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
9
Novel Risk Factors
• Hyperhomocysteinemia
• Infection and inflammation
• Additional genetic factors– Hemostatic and coagulation disorders
• Leisure time inactivity and obesity
• Fast food restaurant abuse
• Second hand smoke
![Page 10: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/10.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
10
Hyperhomocysteinemia
• HC is a highly reactive amino acid toxic to vascular endothelium– Pro-atherogenic and pro-thrombotic effect on
blood vessels
• HC can potentiate the auto-oxidation of LDL
• HC is emerging as a potentially modifiable risk factor for atherosclerosis
![Page 11: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/11.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
11
Infection and Inflammation
• Infectious agents contribute to initiation and chronic formation, progression and activation of atherosclerotic plaques.
• Infectious agents can be seen as triggers
![Page 12: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/12.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
12
Infection and Inflammation
Chlamydia pneumoniae Helicobacter pylori
• Cytomegalovirus
• Herpes virus Periodontal disease Genetic influence
![Page 13: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/13.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
13
Chlamydia Pneumoniae
• Obligate intracellular parasite Infects mononuclear phagocytes
• Macrophages derived from them localize in atherosclerotic plaque to provide mechanism for entry of organism into vessel wall
![Page 14: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/14.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
14
Helicobacter pylori
• Thought to be a potential factor in causing pathophysiology of atherosclerosis
• One strain was found to be associated with increased cytokine expression.
![Page 15: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/15.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
15
Periodontal Disease
• A mechanism for chronic systemic inflammation from Gm (-) organisms
• Advanced disease estimated prevalence:– 15% -60-64 yo– >45% in >65 y.o.
• One study showed a significant ischemic stroke risk (RR 2.1) among those with periodontitis.
![Page 16: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/16.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
16
Genetic Inflammatory Disorders
• Genetic mutations & gene polymorphisms
– Associated with inflammatory pathways– May lead to increased susceptibility to
develop atherosclerosis– Particular HLA types
![Page 17: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/17.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
17
Genetic Inflammatory Disorders
• Continuing research in linkage analysis studies and association studies with genetic influence based on risk factor exposure are needed.
![Page 18: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/18.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
18
Genetic Hemostatic & Coagulation Factors
• Sickle cell disease
• CADASIL
• Coagulation disorders
• Connective tissue disorders
• Vasculopathies
• Metabolic disorders
![Page 19: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/19.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
19
CADASIL
• Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopahty– monogenic inherited small vessel disease– Notch 3 gene on chromosome 19q12– Migraines, TIAs, lacunar strokes– Stroke and dementia in early middle age
![Page 20: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/20.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
20
Fast Food Restaurant Abuse
• Increased trans fatty acid intake from foods fried in partially hydrogenated fats at fast food restaurants– Trans unsaturated fatty acids LDL and HDL– Major contributor is hydrogenated fats
• Builds plaque in arteries
![Page 21: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/21.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
21
Leisure Time Inactivity and Obesity
• Obesity defined as BMI>30kg/m2
with age– Associated with BP, glucose, lipids*
*Walker et al: Am J Epi 1996
![Page 22: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/22.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
22
Guidelines for Stroke Prevention
• Antiplatelets & anticoagulation
• HTN control
• Statin agents
• RAAS inhibition
• Leisure time activity
• Dietary guidelines
![Page 23: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/23.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
23
Guidelines for Stroke Prevention
Aspirin and Sub Q heparin for inpatient with acute stroke
IV heparin for TIA from symptomatic carotid stenosis, until CEA
Bottom line: ASA/ext. release dipyridamole better than aspirin alone, may be better than clopidogrel
![Page 24: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/24.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
24
Use of Anticoagulant Therapy
• Coagulopathies (INR 2-3), prosthetic heart valves( INR 2.5-3.5)
• Nonvalvular atrial fibrillation (INR 2-3)– Age <65, no risk factors Aspirin– Age <65, /c risk factors Warfarin– Age 65-75, no risk factors Aspirin or Warfarin– Age 65-75 /c risk factors Warfarin– Age >75, /c or /s Warfarin
![Page 25: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/25.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
25
Hypertension Control
• SBP<140mmHg & DBP<90mmHG
• <135/<85 if target organ damage
• Antihypertensive medications
• Lifestyle modification
![Page 26: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/26.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
26
Leisure Time Inactivity and Obesity
• Walking AM &PM 1.8 mi/d most days of week will modify risk of cardiovascular disease and stroke**.
*Walker et al: Am J Epi 1996; **Rexrode et al:JAMA 1997.**Abbott RD et al: Am J Epi 1994
![Page 27: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/27.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
27
Leisure Time Activity
Leisure Time Activity
• Exercise will insulin resistance, fibrinogen, LDL and weight and will HDL
– There is no dose relationship with level of activity
![Page 28: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/28.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
28
Novel Approaches to Stroke Prevention
• Statin agents used for hyperlipidemia may reduce risk of stroke*.
• Antihypertensive agents that inhibit the renin-angiotensin –aldosterone system (RAAS) may reduce risk by non-hypertensive lowering mechanisms**.
*Plehn et al: Circ 1999; LIPID Study Gp: N Engl J Med 1998
**Van Bortel et al: Am J Card 1995; Thybo et al: HTN 1995
![Page 29: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/29.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
29
Stroke Prevention Therapy
• AHA Dietary Guidelines, 2000*– General population– Special populations– Ancillary lifestyle issues
• BMI120% of ideal body weight for height
Krauss et al, Stroke 2000.
![Page 30: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/30.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
30
Physician-Community Knowledge Gap
• Well-defined stroke prevention measures underutilized, misapplied
• Knowledge of risk factors for primary stroke prevention– CME, physician recertification– Promote stroke prevention legislation
![Page 31: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/31.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
31
U.S. Legislative Measures
• Public education and awareness of stroke• Improved stroke care• Kennedy Bill
– Establish a national clearinghouse on stroke treatment & research
– Authorize a national public awareness and education plan
– Provide state grants to ensure stroke patients have access to high quality care
![Page 32: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/32.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
32
STOP Stroke Act
• Stroke Treatment and Ongoing Prevention• Public awareness campaign• Grant program• Ensure training in prevention & treatment for
medical personnel• Create comprehensive research for best
practices, barriers, disparities; measure effect of public awareness efforts.
![Page 33: Thursday, June 14, 2001 Congress of Epidemiology 2001Toronto, Canada 1 Stroke Epidemiology-2001 Aurora K. Pajeau, M.D., MPH Stroke Director LSUHSC-Shreveport.](https://reader035.fdocuments.us/reader035/viewer/2022062518/56649ebc5503460f94bc514e/html5/thumbnails/33.jpg)
Thursday, June 14, 2001
Congress of Epidemiology 2001Toronto, Canada
33
STOP Stroke Act
Stroke legislation hot line:
www.stroke.org/strokesmart.cfm